Strategy, advocacy and partnering for the orphan drug industry
”Interesting topics. Well organised. Excellent partnering opportunities.”
Sixera Pharma
The future of rare diseases and orphan drugs
- Discuss pressing issues such as the pricing and reimbursement debate, commercialisation challenges and engaging with patients during research and development of new therapies.
- Meet and interact with representatives from pharma, biotechs, payers, government, regulators, academia and patient groups.
- Use extended networking time to seek out and build partnerships to speed up the development of orphan drugs.
- Network with attendees of our co-located World Gene Therapy Congress.
Should you sponsor?
Why get involved?
Find out more about how you can promote your products at the orphan drug sector’s premier event by downloading the sponsorship brochure today.
"WODC is the key annual congress for anybody working in the rare disease arena.”
Oxford PharmaGenesis
Why sponsor?
- Speak to a room full of orphan drug experts
- Host a roundtable and meet your customers
- Let us organise 1-2-1 meetings for you
- Let us generate sales leads pre-event
- Take a private meeting room
Why exhibit?
- Show off your latest products & innovations
- Promote new services
- Educate your target market
- Generate new sales leads
- Raise brand profile
2015 sponsor & exhibitors
Gold Sponsor
Gold Sponsor
Gold Sponsor
Silver Sponsor
Silver Sponsor
Associate Sponsor
Associate Sponsor
Associate Sponsor
Associate Sponsor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Co-located with
Interactive Sessions Offer High Level Networking
“WODC is the key annual congress for anybody working in the rare disease arena.”
Oxford Pharmagenesis
“Well organised, good programme and most useful, the networking sessions.”
AlepSyr Biotech Consultancy
“The event was excellent for networking and gathering information.”
Ataxia South Wales
Be part of the conversation
Obama’s Precision Medicine Initiative: What It Means for Orphan Drugs
In last night’s State of the Union (SOTU) address, President Barack Obama brought to the forefront of the nation something that we in the Orphan ...
The post Obama’s Precision Medicine Initiative: What It Means for Orphan Drugs appeared first on Orphan Drugs.
Australian Orphan Drug System is Inadequate and Failing Patients
“Under Australia’s current system many Australians will never be able to afford to access [rare disease] treatments” This was the blunt conclusion of a report published ...
The post Australian Orphan Drug System is Inadequate and Failing Patients appeared first on Orphan Drugs.
Mexico’s Most Common Rare Diseases
Awareness of rare diseases in Mexico has increased notably by means of the media, internet and of course the work of patient groups that demand ...
The post Mexico’s Most Common Rare Diseases appeared first on Orphan Drugs.
Join the Community
Strategy and innovation for the orphan drug and rare disease industry
Sign Up to Our Newsletter
